TSMHT
WST icon

Thurston Springer Miller Herd & Titak’s West Pharmaceutical WST Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.79K Hold
5
– – ﹤0.01% 1105
2026
Q1 		$1.25K Hold
5
– – ﹤0.01% 1231
2025
Q4 		$1.38K Buy
+5
New +$1.37K ﹤0.01% 1259

Other funds holding WST

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's WST Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak held its West Pharmaceutical (WST) position steady in Q2 2026 at 5 shares worth $1.79K. The position accounts for ﹤0.01% of the portfolio, ranked #1105.

Thurston Springer Miller Herd & Titak first reported a position in WST in Q4 2025 and has held it in 3 quarters since. 240 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Thurston Springer Miller Herd & Titak held 5 shares of West Pharmaceutical worth $1.79K as of Q2 2026.
  • Thurston Springer Miller Herd & Titak left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #1105 holding.
  • Thurston Springer Miller Herd & Titak first reported a position in West Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • 240 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.